Embecta (EMBC) Other Non-Current Assets (2021 - 2022)
Embecta's (EMBC) quarterly Other Non-Current Assets came in at $68.5 million in Q2 2022, up 312.65% quarter-over-quarter from $16.6 million in Q1 2022.
Embecta (EMBC) Other Non-Current Assets (2021 - 2022) Analysis & Trends
Embecta has disclosed Other Non-Current Assets across 2 years of filings, most recently posting $68.5 million for Q2 2022.
- Other Non-Current Assets for Q2 2022 came in at $68.5 million, changed N/A year-over-year; the trailing twelve-month figure through Jun 2022 was $68.5 million (changed N/A YoY), and the FY2021 annual result was $11.3 million, changed N/A from the prior year.
- Other Non-Current Assets came in at $68.5 million for Q2 2022 at Embecta, up from $16.6 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $68.5 million in Q2 2022 to a low of $11.2 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 2.43 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 446.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 210.73 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 81.30 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 848.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 672.80 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 39.83 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 692.00 Mn |
| 10 | Embecta | 183.23 Mn | -10.17 Mn | 127.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 68.50 Mn |
| Mar 31, 2022 | 16.60 Mn |
| Dec 31, 2021 | 11.20 Mn |
| Sep 30, 2021 | 11.30 Mn |